CADET was established to employ mass-spectrometric-based analysis of trace elements, metabolites (metabolomics) and proteins (proteomics) to identify and developing new and improved therapeutics. This is done by investigating the molecular mechanisms of chronic non-communicable diseases. Our main disease targets are:
- diabetes mellitus and its complications;
- chronic cardiovascular diseases;
- adult-onset dementia, particularly Alzheimer’s disease;
- age-related macular degeneration (AMD).
See further introductory information (pdf PDF 183 KB)
Public Engagement and Press Releases.
- Kirsty McIntyre wins first prize in the university's Three Minute Thesis event
- Diabetes UK event at Cheetham's School of Music
Richard Unwin gave a talk at this event for donors and patients
- Richard Unwin receives a Commendation from the university's 'Making a Difference Awards'
- I'm a Scientist, Get Me Out of Here
Richard Unwin took part in this Wellcome Trust funded event in November
- What's Wrong with Teddy
CADET had a stand at the Science Spectacular during Manchester Science Festival
- British Heart Foundation Red Box event
Amy Watkins, one of our PhD students, took part in this event in London during September